TSXV:APC.H - Post by User
Post by
Goldnboy1on Feb 05, 2022 1:31am
309 Views
Post# 34400437
News! Clinicals in 2022!
News! Clinicals in 2022! Animal studies in spring, with expectation of using results to leap into clinicals!
News says they continue to speak to potential licensees!
At this market cap the re rate will be rapid if the right deal done.
Remember historically pre roll back this often traded at $40-$60m market cap. Wouldn't be easy to return there if we are pushing forward on clincals.
Management has eyes on a few drugs that failed in Stage 3. Could be a chance $APC's patents could revive study of these failed drugs. Majority fail for off target toxicity. Which is our strength at preventing.
Stay tuned!
Miner maybe you should average down.